SCHEMBL21075247

SCHEMBL21075247

CC(=O)N1CCC[C@H]1C(=O)NO

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 1/20 0.45
F2 P00734 1/20 0.45
KDM4E B2RXH2 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
REN P00797 1/20 0.42
CHRM2 P08172 3/20 0.41
CHRM4 P08173 3/20 0.41
CHRM5 P08912 3/20 0.41
CHRM1 P11229 3/20 0.41
CHRM3 P20309 3/20 0.41
ACE P12821 1/20 0.40
TNKS O95271 1/20 0.39
MMP2 P08253 1/20 0.39
MMP9 P14780 1/20 0.39
POLB P06746 1/20 0.39
MAPK10 P53779 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17327534 0.94 CHRM2 (0.44) P2RX7F2KDM4ESMN1; SMN2CHRM2
SCHEMBL13403369 0.88 MMP2 (0.37) P2RX7F2CHRM2CHRM4CHRM5
SCHEMBL12258952 0.85 P2RX7 (0.45) P2RX7F2KDM4ESMN1; SMN2CHRM2
SCHEMBL406540 0.85 P2RX7 (0.45) P2RX7F2KDM4ESMN1; SMN2CHRM2
SCHEMBL10136486 0.85 P2RX7 (0.45) P2RX7F2KDM4ESMN1; SMN2CHRM2
SCHEMBL17069029 0.83 F2 (0.47) P2RX7F2KDM4ESMN1; SMN2CHRM2
SCHEMBL2757971 0.81 POLB (0.47) P2RX7F2KDM4ESMN1; SMN2TNKS
SCHEMBL17069028 0.81 P2RX7 (0.43) P2RX7F2KDM4ESMN1; SMN2TNKS
SCHEMBL3279377 0.80 P2RX7 (0.51) P2RX7F2KDM4ESMN1; SMN2TNKS
SCHEMBL13629804 0.79 CHRM2 (0.42) CHRM2CHRM4CHRM5CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3166939-B1 THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF GENENTECH INC (US) 2019-06-05 EP disclosed